SQI Diagnostics Inc. Receives ISO 13485 Certification
SQI Diagnostics Inc. announced that it has been awarded its ISO 13485:2003 certification for its quality management system for the Design and Development, Production, Distribution, Installation and Servicing of its In Vitro Diagnostics systems (Microarray Platforms and Consumable Kits). This milestone further reinforces SQI Diagnostics' efforts to develop and manufacture high-quality medical systems and tests for the healthcare market, according to the company.
"The certification and implementation of a Quality Management System in accordance with ISO 13485 demonstrates that we are well positioned to manufacture and distribute our SQiDworks(TM) platform and QuantiSpot(TM) panels at the standards required by our international customers," said Claude Ricks, CEO of SQI Diagnostics. "This accomplishment brings us a step closer to commercialization of our first products. We expect to complete the validation studies of our automated microarray platform and multiplexed rheumatoid arthritis test panel in the coming months."
Most read news
Organizations
Other news from the department politics & laws

Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.